A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
സെൻസെക്സ്
74,197.65
▲ +0.26%
നിഫ്റ്റി
23,189.40
▲ +0.31%
സ്വർണ്ണം
₹ 14,065/gm
വെള്ളി
₹ 2,50,000/kg
പെട്രോൾ
₹ 115.49
ഡീസൽ
₹ 104.40
എൽപിജി
₹ 951.00
ക്രൂഡ് ഓയിൽ
$ 108.07
USD
₹ 95.86
സെൻസെക്സ്
74,197.65
▲ +0.26%
നിഫ്റ്റി
23,189.40
▲ +0.31%
സ്വർണ്ണം
₹ 14,065/gm
വെള്ളി
₹ 2,50,000/kg
പെട്രോൾ
₹ 115.49
ഡീസൽ
₹ 104.40
എൽപിജി
₹ 951.00
ക്രൂഡ് ഓയിൽ
$ 108.07
USD
₹ 95.86
ITI Pharma and Healthcare Fund
Regular
Direct
3 Year Absolute Returns
59.34% ↑
NAV (₹) on 15 Sep 2026
17.81
1 Day NAV Change
-1.48%
Risk Level
Very High Risk
Rating
-
ITI Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by ITI Asset Management Limited. Launched on 18 Oct 2021, investors can start with a minimum SIP of ₹100 or a ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
18 Oct 2021
Min. Lumpsum Amount
₹ 5,000
Fund Age
4 Yrs
AUM
₹ 276.23 Cr.
Benchmark
NIFTY Healthcare Total Return Index
Expense Ratio
2.63%
Scheme Type
Open Ended
Exit Load
0.5%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 276.23 Cr
Equity
99.27%
Other Assets & Liabilities
0.73%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 73.43% |
| Hospitals & Medical Services | 22.10% |
| Medical Equipment & Accessories | 1.50% |
| Plastics - Plastic & Plastic Products | 1.25% |
| Industrial Gases | 0.99% |
| Net Receivables/(Payables) | 0.73% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 12.58% | ₹ 34.76 | Pharmaceuticals |
| Divi's Laboratories Limited | 9.23% | ₹ 25.50 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 5.72% | ₹ 15.79 | Hospitals & Medical Services |
| Max Healthcare Institute Limited | 4.84% | ₹ 13.37 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Limited | 4.75% | ₹ 13.13 | Pharmaceuticals |
| Dr. Reddy's Laboratories Limited | 4.31% | ₹ 11.91 | Pharmaceuticals |
| Cipla Limited | 4.22% | ₹ 11.67 | Pharmaceuticals |
| Laurus Labs Limited | 4.02% | ₹ 11.11 | Pharmaceuticals |
| Aurobindo Pharma Limited | 3.97% | ₹ 10.96 | Pharmaceuticals |
| Mankind Pharma Limited | 3.31% | ₹ 9.15 | Pharmaceuticals |
| Neuland Laboratories Limited | 3.18% | ₹ 8.79 | Pharmaceuticals |
| Cohance Lifesciences Limited | 3.10% | ₹ 8.57 | Pharmaceuticals |
| Global Health Limited | 2.98% | ₹ 8.23 | Hospitals & Medical Services |
| Alkem Laboratories Limited | 2.92% | ₹ 8.06 | Pharmaceuticals |
| Fortis Healthcare Limited | 2.82% | ₹ 7.80 | Hospitals & Medical Services |
| Lupin Limited | 2.43% | ₹ 6.71 | Pharmaceuticals |
| Abbott India Limited | 1.97% | ₹ 5.43 | Pharmaceuticals |
| IPCA Laboratories Limited | 1.92% | ₹ 5.30 | Pharmaceuticals |
| Shilpa Medicare Limited | 1.59% | ₹ 4.39 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.59% | ₹ 4.40 | Pharmaceuticals |
| Healthcare Global Enterprises Limited | 1.55% | ₹ 4.29 | Hospitals & Medical Services |
| Poly Medicure Limited | 1.50% | ₹ 4.14 | Medical Equipment & Accessories |
| Aster DM Quality Care Limited | 1.47% | ₹ 4.05 | Hospitals & Medical Services |
| Piramal Pharma Limited | 1.32% | ₹ 3.65 | Pharmaceuticals |
| Shaily Engineering Plastics Limited | 1.25% | ₹ 3.46 | Plastics - Plastic & Plastic Products |
| Anthem Biosciences Limited | 1.25% | ₹ 3.45 | Pharmaceuticals |
| Glenmark Pharmaceuticals Limited | 1.15% | ₹ 3.18 | Pharmaceuticals |
| Thyrocare Technologies Limited | 1.05% | ₹ 2.90 | Hospitals & Medical Services |
| GlaxoSmithKline Pharmaceuticals Limited | 1.02% | ₹ 2.81 | Pharmaceuticals |
| Linde India Limited | 0.99% | ₹ 2.74 | Industrial Gases |
| Rainbow Childrens Medicare Limited | 0.93% | ₹ 2.57 | Hospitals & Medical Services |
| Biocon Limited | 0.87% | ₹ 2.41 | Pharmaceuticals |
| Supriya Lifescience Limited | 0.81% | ₹ 2.23 | Pharmaceuticals |
| Metropolis Healthcare Limited | 0.74% | ₹ 2.04 | Hospitals & Medical Services |
| Net Receivables / (Payables) | 0.73% | ₹ 1.96 | Others |
| Zydus Lifesciences Limited | 0.71% | ₹ 1.95 | Pharmaceuticals |
| Caplin Point Laboratories Limited | 0.61% | ₹ 1.69 | Pharmaceuticals |
| Syngene International Limited | 0.60% | ₹ 1.66 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 12.46% | 8.60% | 1.95% | 16.80% |
| Category returns | 3.34% | 3.85% | 2.63% | 19.22% |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. ... Read more
AMC Details
Name
ITI Asset Management Limited
Date of Incorporation
14 May 2018
CEO
Mr. Jatinder Pal Singh
CIO
Mr. Rajesh Bhatia
Type
Pvt.Sector-Indian
Address
ITI House 36,
Dr. R. K. Shirodkar Marg,
Parel Mumbai, Maharashtra, India - 400012
Website
https://www.itiamc.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.68 | 112.59% | 288.37% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹33.31 | 109.75% | 272.68% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.08 | 19.59% | 150.97% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29 | 18.43% | 142.90% | 0.00% | ₹11,478 | 1.78% |
Very High
|
Top Funds from ITI Asset Management Limited
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹37.74 | 18.42% | 89.95% | 134.95% | ₹3,603 | 0.86% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹33.43 | 16.70% | 81.25% | 115.49% | ₹3,603 | 2.22% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹35.78 | 16.03% | 80.07% | 122.73% | ₹3,603 | 0.86% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹35.78 | 16.03% | 80.07% | 122.73% | ₹3,603 | 0.86% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹31.52 | 14.05% | 70.89% | 103.17% | ₹3,603 | 2.22% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹31.52 | 14.05% | 70.89% | 103.17% | ₹3,603 | 2.22% |
Very High
|
|
ITI Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹25.25 | 9.12% | 69.20% | 108.84% | ₹1,539 | 0.94% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹19.61 | 10.59% | 68.50% | 0.00% | ₹276 | 0.92% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹19.60 | 10.57% | 68.48% | 0.00% | ₹276 | 0.92% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹19.60 | 10.57% | 68.48% | 0.00% | ₹276 | 0.92% |
Very High
|
FAQs
What is the current NAV of ITI Pharma and Healthcare Fund Regular Growth?
The current Net Asset Value (NAV) of ITI Pharma and Healthcare Fund Regular Growth is ₹17.81 as of 15 Sep 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of ITI Pharma and Healthcare Fund Regular Growth?
The Assets Under Management (AUM) of ITI Pharma and Healthcare Fund Regular Growth is ₹276.23 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of ITI Pharma and Healthcare Fund Regular Growth?
ITI Pharma and Healthcare Fund Regular Growth has delivered returns of 8.60% (1 Year), 16.80% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of ITI Pharma and Healthcare Fund Regular Growth?
ITI Pharma and Healthcare Fund Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for ITI Pharma and Healthcare Fund Regular Growth?
The minimum lumpsum investment required for ITI Pharma and Healthcare Fund Regular Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+
X
